Pages: [1]
0 Members and 1 Guest are viewing this topic.
Pages: [1]
|
Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
Started by mastercode |
Replies: 0 Views: 1353 |
by mastercode |
|
Black Diamond Group Limited Announces Approval of All Resolutions at 2025 Annual Meeting
Started by mastercode |
Replies: 0 Views: 259 |
by mastercode |
|
Citizens JMP downgrades Ibotta stock on product delays and limited revenue visibility
Started by mastercode |
Replies: 0 Views: 177 |
by mastercode |
|
Investec Limited share incentive plan acquires 300,000 shares
Started by mastercode |
Replies: 0 Views: 109 |
by mastercode |
|
Fenikso Limited halves Savanah loan in renegotiation deal
Started by mastercode |
Replies: 0 Views: 376 |
by mastercode |


Similar topics (5)